论文部分内容阅读
Enhancer of Zeste homolog 2(EZH2) is closely correlated with malignant tumor and regarded as a promising target to treat B-cell lymphoma. In our research, the molecular docking and three-dimensional quantitative structure-activity relationships(3D-QSAR) s